5-CHLORO-7-{[9-(1,2,3,4-TETRAHYDROYCRIDIN-9-YLAMINO)-NONYLAMINO]-METHYL}-QUINOLIN-8-OL
Compound with spectra: 1 NMR
![5-CHLORO-7-{[9-(1,2,3,4-TETRAHYDROYCRIDIN-9-YLAMINO)-NONYLAMINO]-METHYL}-QUINOLIN-8-OL](/api/compound/2FC0rLR2Qyd.png?ph=true&h=300&w=458 "5-CHLORO-7-{[9-(1,2,3,4-TETRAHYDROYCRIDIN-9-YLAMINO)-NONYLAMINO]-METHYL}-QUINOLIN-8-OL")
| SpectraBase Compound ID | 2FC0rLR2Qyd |
|---|---|
| InChI | InChI=1S/C32H40ClN5O/c33-27-21-23(32(39)31-24(27)15-12-19-35-31)22-34-18-10-4-2-1-3-5-11-20-36-38-30-25-13-6-8-16-28(25)37-29-17-9-7-14-26(29)30/h6,8,12-13,15-16,19,21,34,36,39H,1-5,7,9-11,14,17-18,20,22H2,(H,37,38) |
| InChIKey | IHQOXUXUVVNMEK-UHFFFAOYSA-N |
| Mol Weight | 546.2 g/mol |
| Molecular Formula | C32H40ClN5O |
| Exact Mass | 545.292139 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl2 |
N,N-[1',2',3',4'-Tetrahydroacrydin-9'-yl]-N-[8"-(1"',2''',3''',4''-tetrahydroacridin-9'"-yl)oct-7"-en-1"-yl]-amine
2-(4-benzoyl-1-piperazinyl)-N-[1-(phenylmethyl)-2,3-dihydropyrrolo[2,3-b]quinolin-4-yl]acetamide
acetamide, N-(1,2,3,4-tetrahydro-3,3-dimethyl-1-oxo-9-acridinyl)-
11H-Indolo[3,2-g]indolizine, 1,2,3,5,6,11b-hexahydro-2,11b-dimethyl-
9-[(4-Chlorobenzyl)amino]-3,3-dimethyl-1,2,3,4-tetrahydro-1-acridinol
9-BENZYL-3-ETHYL-1,2,3,9-TETRAHYDROCARBAZOL-4-ONE
(3R,12bS)-3-ethyl-1,2,3,4,6,7,12,12b-octahydropyrido[6,1-a]$b-carboline-4-carbonitrile
9-Acridinecarboxylic acid, 1,2,3,4-tetrahydro-, 2-(3-methoxyphenyl)-2-oxoethyl ester
N-(2-Hydroxyphenyl)-1,2,3,4-tetrahydro-9-acridinecarboxamide
9-BENZYL-3,3-DIMETHYL-1,2,3,9-TETRAHYDROCARBAZOL-4-ONE
| Title | Journal or Book | Year |
|---|---|---|
| Novel Tacrine−8-Hydroxyquinoline Hybrids as Multifunctional Agents for the Treatment of Alzheimer’s Disease, with Neuroprotective, Cholinergic, Antioxidant, and Copper-Complexing Properties | Journal of Medicinal Chemistry | 2010 |